Home > Financial Ratios > DR REDDYS LABORATORIES

DR REDDYS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
DR REDDYS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Top Undervalued Large Cap Stocks
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DR REDDYS LABORATORIES
Please provide your vote to see the results

DR REDDYS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 19.2274.142.1834.63-12.08

What is the latest Core EBITDA Growth ratio of DR REDDYS LABORATORIES ?

The latest Core EBITDA Growth ratio of DR REDDYS LABORATORIES is 19.22 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202419.22
Mar202374.14
Mar20222.18
Mar202134.63
Mar2020-12.08

How is Core EBITDA Growth of DR REDDYS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 19.22
-74.08
Mar2023 74.14
3,300.92
Mar2022 2.18
-93.70
Mar2021 34.63
Positive
Mar2020 -12.08 -

Other Financial Ratios of DR REDDYS LABORATORIES


Compare Core EBITDA Growth ratio of peers of DR REDDYS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DR REDDYS LABORATORIES ₹95,471.0 Cr -5.5% 1.6% -5.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,393.0 Cr -2.8% 7.6% 8.4% Stock Analytics
DIVIS LABORATORIES ₹153,258.0 Cr -2.3% 0.8% 72.7% Stock Analytics
CIPLA ₹116,434.0 Cr -5.4% -1.5% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,474.0 Cr -0.8% 6.8% 25.6% Stock Analytics
MANKIND PHARMA ₹99,974.0 Cr 2.1% 3.7% 9.5% Stock Analytics


DR REDDYS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DR REDDYS LABORATORIES

-5.5%

1.6%

-5.1%

SENSEX

0.7%

4%

6.3%


You may also like the below Video Courses